Valine-Citrulline Based Enzymatically Cleavable Linkers

Valine-Citrulline Based Enzymatically Cleavable Linkers

Published on 27/10/2020

Iris Biotech presents its selection of Val-Cit-based linkers, a dipeptide motif frequently utilized for the development of ADCs with increased serum stability and high cleavage efficiency.

The conjugation of highly potent small drug molecules to target specific biomolecules, like antibodies, is a sophisticated approach, particularly in the field of cancer therapy. Such a synergistic combination allows to circumvent the disadvantages of antibodies, like low potency, as well as the drawbacks of small drug molecules, like low specificity and unwanted side effects.

Linkers, which are implemented to combine both moieties, need to provide sufficient stability during systemic circulation while providing rapid and efficient release of the cytotoxic drug in its active state upon reaching its target.

To fully suit the application’s needs, various linker systems have emerged, including permanent linkers as well as chemically or enzymatically cleavable ones. The latter ones include peptide linkers, which are distinguished by their increased serum stability as well as rapid enzymatic release upon internalization into the target cell. First generation peptide linkers like Gly-Phe-Leu-Gly and Ala-Leu-Ala-Leu were prone to aggregation of the conjugates as well as slow drug release. These limitations are tackled by utilizing dipeptides, such as the Valine-Citrulline motif.

The Val-Cit fragment serves as substrate for cathepsin, a lysosomal protease, which is typically not found extracellularly except under pathological conditions, e.g. in metastatic tumors. Cleavage of the amide bond by hydrolysis is followed by a 1,6-elimination of the para amino benzyl alcohol (PABC) spacer, fragmentation, and traceless release of the drug molecule inside the cell.

Valyl-citrullyl dipeptide fragment as recognition motif of cathepsin undergoes cleavage by hydrolysis leading to a 1,6-elimination with fragmentation and traceless release of the drug molecule.

This prominent motif was utilized by Seattle Genetics for the development of the ADC Adcetris®, which is used for the treatment of Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma.

Composition of Adcetris®.

➔ Please click here to see various examples of Val-Cit-based linkers on our Website

➔ Those derivatives are also available based on the Val-Ala motif

Our knowledge and products for linker technologies and ADC design are summarized in our brochure Linkerology, which is available for download free of charge on our Webpage.


To facilitate the development of new ADCs suitable for your desired application, we offer a broad range of protected (Fmoc, Boc) as well as prefunctionalized peptide linkers, e.g. derivatives with a maleimide moiety or bearing an alkyne or azide moiety, which can easily be used for further conjugation via Click reaction.

Examples for Vit-Cit-based dipeptide linkers available from Iris Biotech.

➔ You could not find your derivative of choice? Please get in contact for a custom synthesis

References:

  • Catepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro nticancer Activity. G. M. Dubowchik, R. A. Firestone, L. Padilla, D. Willner, S. J. Hofstead, K. Mosure, J. O. Knipe, S. J. Lasch, and P. A. Trail; Bioconjugate Chem. 2002; 13: 855-869. https://doi.org/10.1021/bc025536j.
  • Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design. M. Dorywalska, R. Dushin, L. Mine, S. E. Farias, D. Zhou, T. Navaratnam, V. Lui, A. Hasa-Moreno, M. G. Casas, T.-T. Tran, K. Delaria, S.-H. Liu, D. Foletti, C. J. O’Donnell, J. Pons, D. L. Shelton, A. Rajpal, and P. Strop; Mol. Cancer Ther. 2016; 15: 958-970. https://doi.org/10.1158/1535-7163.MCT-15-1004.
  • Arming antibodies: prospects and challenges for immunoconjugates. A. M. Wu, P. D. Senter; Nat. Biotechnol. 2005; 23(9): 1137-1146. https://doi.org/10.1038/nbt1141.
  • Linker technologies for antibody-drug conjugates. B. Nolting; Methods Mol. Biol. 2013; 1045: 71-100. https://doi.org/10.1007/978-1-62703-541-5_5.
  • Current ADC linker chemistry. N. Jain, S. W. Smith, S. Ghone, B. Tomczuk; Pharm. Res. 2015; 32: 3526-3540. https://doi.org/10.1007/s11095-015-1657-7.
  • Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry. J. R. McCombs, S. C. Owen; AAPS J. 2015; 17(2): 339-351. https://doi.org/10.1208/s12248-014-9710-8.
Related Products
    1. Structure image for Boc-Val-Cit-PAB-PNP
      Boc-Val-Cit-PAB-PNP

      Product code: ADC1010

      Starting at $168.75

    2. Structure image for Fmoc-Val-Cit-PAB-PNP
      Fmoc-Val-Cit-PAB-PNP

      Product code: ADC1000

      Starting at $168.75

    3. Structure image for Boc-Val-Cit-PAB
      Boc-Val-Cit-PAB

      Product code: ADC1020

      Starting at $303.75

    4. Structure image for Fmoc-Val-Cit-PAB
      Fmoc-Val-Cit-PAB

      Product code: ADC1030

      Starting at $303.75

    5. Structure image for Mal-Dap(Boc)-Val-Cit-PAB-PNP
      Mal-Dap(Boc)-Val-Cit-PAB-PNP

      Product code: ADC1090

      Starting at $337.50

    6. Structure image for 6-Azidohexanoyl-Val-Cit-PAB
      6-Azidohexanoyl-Val-Cit-PAB

      Product code: ADC1120

      Starting at $438.75

    7. Structure image for 6-Azidohexanoyl-Val-Cit-PAB-PNP
      6-Azidohexanoyl-Val-Cit-PAB-PNP

      Product code: ADC1130

      Starting at $506.25

    8. Structure image for Azido-PEG(4)-Val-Cit-PAB
      Azido-PEG(4)-Val-Cit-PAB

      Product code: ADC1160

      Starting at $607.50

    9. Structure image for Azido-PEG(4)-Val-Cit-PAB-PNP
      Azido-PEG(4)-Val-Cit-PAB-PNP

      Product code: ADC1170

      Starting at $675.00

    10. Structure image for 4-Pentynoyl-Val-Cit-PAB
      4-Pentynoyl-Val-Cit-PAB

      Product code: ADC1140

      Starting at $438.75

    11. Structure image for 4-Pentynoyl-Val-Cit-PAB-PNP
      4-Pentynoyl-Val-Cit-PAB-PNP

      Product code: ADC1150

      Starting at $506.25

    12. Structure image for Alkyne-PEG(4)-Val-Cit-PAB
      Alkyne-PEG(4)-Val-Cit-PAB

      Product code: ADC1180

      Starting at $607.50

    13. Structure image for Alkyne-PEG(4)-Val-Cit-PAB-PNP
      Alkyne-PEG(4)-Val-Cit-PAB-PNP

      Product code: ADC1190

      Starting at $675.00

    14. Structure image for DBCO-C6-Val-Cit-PAB-PNP
      DBCO-C6-Val-Cit-PAB-PNP

      Product code: ADC1260

      Starting at $405.00

    15. Structure image for Fmoc-Val-Cit-PAB-NMeCH2CH2NMe-Boc
      Fmoc-Val-Cit-PAB-NMeCH2CH2NMe-Boc

      Product code: ADC1240

      Starting at $236.25

    16. Structure image for MC-Val-Cit-PAB
      MC-Val-Cit-PAB

      Product code: ADC1100

      Starting at $405.00

    17. Structure image for MC-Val-Cit-PAB-PNP
      MC-Val-Cit-PAB-PNP

      Product code: ADC1110

      Starting at $236.25

    18. Structure image for DTM-C6-Val-Cit-PAB
      DTM-C6-Val-Cit-PAB

      Product code: ADC1440

      Starting at Please inquire

    19. Structure image for DTM-C6-Val-Cit-PAB-PNP
      DTM-C6-Val-Cit-PAB-PNP

      Product code: ADC1450

      Starting at Please inquire

    20. Structure image for Mal-PEG(4)-Val-Cit-PAB
      Mal-PEG(4)-Val-Cit-PAB

      Product code: ADC1200

      Starting at $675.00